4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027017
Director bought 180,000 shares at $17.00 ($3,060,000)
- Director acquired 13,871,446 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jerel Davis Director | 2021-06-29 | Conversion | +12,343,727 | 14,708,398 | I: show line 1 in the form | ||
| Jerel Davis Director | 2021-06-29 | Conversion | +1,527,719 | 1,527,719 | I: show line 2 in the form | ||
| Jerel Davis Director | 2021-06-29 | Purchase | +180,000 | $17.00 | $3,060,000 | 1,707,719 | I: show line 3 in the form |
| Open-market purchases · 180,000 sh · avg $17.00 · $3,060,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jerel Davis Director | 2021-06-29 | Conversion · Series A Preferred Stock | −30,019,945 | 0 | I: show line 4 in the form | ||
| Jerel Davis Director | 2021-06-29 | Conversion · Series B Preferred Stock | −3,715,415 | 0 | I: show line 5 in the form |
Loading xslF345X03/doc4.xml…